Basit öğe kaydını göster

PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification.

dc.contributor.authorFlinn, I. W.
dc.contributor.authorLeonard, J.
dc.contributor.authorReeves, J.
dc.contributor.authorFerhanoglu, B.
dc.contributor.authorDoner, K. T.
dc.contributor.authorEom, H.
dc.contributor.authorRaposo, J.
dc.contributor.authorChowhan, N. M.
dc.contributor.authorSuh, C.
dc.contributor.authorNoga, S.
dc.contributor.authorTumyan, G.
dc.contributor.authorAung, S.
dc.contributor.authorHajdenberg, J.
dc.contributor.authorUlrich, B. K.
dc.contributor.authorPendergrass, K. B.
dc.contributor.authorMulligan, G.
dc.contributor.authorRizo, A.
dc.contributor.authorKussick, S.
dc.contributor.authorOffner, F.
dc.date.accessioned2021-03-05T21:12:23Z
dc.date.available2021-03-05T21:12:23Z
dc.date.issued2011
dc.identifier.citationLeonard J., Reeves J., Ferhanoglu B., Doner K. T. , Eom H., Flinn I. W. , Raposo J., Chowhan N. M. , Suh C., Noga S., et al., "PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification.", JOURNAL OF CLINICAL ONCOLOGY, cilt.29, 2011
dc.identifier.issn0732-183X
dc.identifier.otherav_d7ca30b0-8e40-40a9-97c1-68b0556fcb9d
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/142378
dc.identifier.urihttps://doi.org/10.1200/jco.2011.29.15_suppl.tps226
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectOnkoloji
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.titlePYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification.
dc.typeMakale
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGY
dc.contributor.department, ,
dc.identifier.volume29
dc.identifier.issue15
dc.contributor.firstauthorID200522


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster